Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
We haven't written up this one. Al Jazeera has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Moderna shares soar 150% after personalised cancer vaccine breakthrough indianexpress.com